MedTrace Logo

ECMO Use in Pediatric Oncology and HSCT Patients: A Descriptive and Comparative Analysis

NCT07712835 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2026-07-20

No results posted yet for this study

Summary

This was an observational study, with a descriptive and comparative portion. The descriptive analysis, a large single center experience, examined bleeding complications, infectious rates, and survival outcomes in patients under 18 years old with an underlying oncologic diagnosis and/or hematopoietic stem cell transplant on Extracorporeal membrane oxygenation (ECMO). In a small multicenter cohort, the comparative analysis evaluated survival outcomes in this population with respiratory failure in the presence and absence of ECMO. Children's Mercy Kansas City served as the ECMO cohort; Cincinnati Children's Hospital Medical Center served as the matched non-ECMO cohort.

Conditions

  • ECMO Outcomes
  • Respiratory Failure (Pediatric Patients)
  • Malignancies, Hematologic
  • Solid Tumor Malignancies
  • Hematopoetic Stem Cell Transplant

Interventions

OTHER

Extracorporeal membrane oxygenation (ECMO)

ECMO utilization in patient with malignancy and/or history of hematopoietic stem cell transplant.

Sponsors & Collaborators

  • Children's Hospital Medical Center, Cincinnati

    collaborator OTHER

  • Children's Mercy Hospital Kansas City

    lead OTHER

Eligibility

Min Age
4 Weeks
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2024-12-31
Completion
2025-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07712835 on ClinicalTrials.gov